1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF ARTIFICIAL ORGAN TECHNOLOGY MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET SNAPSHOT
3.2 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ARTIFICIAL LIVER
5.3 ARTIFICIAL PANCREAS
5.4 ARTIFICIAL HEART
5.5 ARTIFICIAL KIDNEY
5.6 BIONIC LIMBS
5.7 OTHERS
6 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 PROSTHETIC
6.3 BIONICS
7 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 U.K.
7.2.3 FRANCE
7.2.4 GERMANY
7.2.5 SPAIN
7.2.6 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 INDIA
7.3.3 CHINA
7.3.4 JAPAN
7.3.5 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 SOUTH AFRICA
7.4.3 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 COMPETATIVE LANDSCAPE
8.1 OVERVIEW
8.2 NEW PRODUCT LAUNCHES
9 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 MEDTRONIC INC.
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 BAXTER INTERNATIONAL INC.
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 COCHLEAR LTD.
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 THORATEC CORPORATION
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 GAMBRO AB
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 EKSO BIONICS
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 BIOMET INC.
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 NANO RETINA INC.
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 BERLIN HEART GmbH
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS